Top Stories
-
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
Topic
-
Parkinson’s patients and their families are increasingly turning to genetic testing to learn more about their disease or risk of passing it on. But testing is complex, and counseling is advised.
Topic
-
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
Topic
-
A newly discovered protein tangle has been associated with multiple neurodegenerative diseases and may have a role in causing the diseases.
Topic
Latest News
- February 18, 2020
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
Topic
- January 15, 2020
The source of essential tremor—involuntary, rhythmic trembling—has been elusive, but a new study points to abnormal electrical activity in the base of the brain.
Topic
- January 2, 2020
Dementia is three times more common in older adults who are illiterate, a new study from Columbia has found.
Topic
- November 22, 2019
Researchers had high hopes for Alzheimer’s drugs that clear amyloid from the brain, but none of the drugs have slowed the disease. Columbia’s Scott Small says he has new reasons to be optimistic.
Topic
- November 14, 2019
A new study finds that cognitive impairment begins in the earliest stages of age-related hearing loss—when hearing is still considered normal.
Topic
- November 1, 2019
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.
Topic
- October 21, 2019
A new study suggests that many different immune cells, not just T cells, are involved in triggering multiple sclerosis (MS).
Topic
- October 2, 2019
Only select neurons die during Parkinson’s disease. Columbia researchers are looking for clues in immune cells to find out what makes these brain cells so vulnerable.
Topic
- August 15, 2019
With several targeted Parkinson’s disease drugs entering clinical trials, a new genetic testing and counseling program may help identify patients who qualify for enrollment.
Topic
- March 20, 2019
Survivors of cardiac arrest are more likely to experience further heart trouble if they have symptoms of PTSD, according to a new study from researchers at Columbia University Irving Medical Center.
Topic
